Medindia

X

Disputed Asthma Drugs Have Safe Record

by Bidita Debnath on  November 27, 2013 at 11:33 PM Research News   - G J E 4
A popular combination asthma therapy dogged by safety concerns has not harmed British Columbians and should remain in use.

This is according to researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.
 Disputed Asthma Drugs Have Safe Record
Disputed Asthma Drugs Have Safe Record
Advertisement

The therapy combines an inhaled corticosteroid to reduce swelling in the airways with "long-acting beta agonists" (LABAs) to ease breathing and reduce the risk of a severe asthma attack. The U.S. Food and Drug Administration (FDA), reacting to claims that LABAs might mask conditions that leave patients vulnerable to more severe or even fatal asthma attacks, ordered the drugs' makers to conduct large-scale safety trials; with results not expected for five years, the FDA urges that LABAs be discontinued once a person's asthma is under control.

Advertisement
The UBC-Vancouver Coastal Health study examined hospitalization rates for patients who took inhaled corticosteroids alone and those who used the combination therapy, covering 46,000 people over 15 years. Although the hospitalization rate for combination therapy users was 14 per cent higher than those who took corticosteroids alone, that difference was not statistically significant.

Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All